Increased Levels of Soluble lnterleukin-2 Receptor in Non-Hodgkin’s Lymphomas: Relationship with Clinical, Histologic, and Phenotypic Features-Reference-Cited by-同舟云学术

Increased Levels of Soluble lnterleukin-2 Receptor in Non-Hodgkin’s Lymphomas: Relationship with Clinical, Histologic, and Phenotypic Features

Published:1989-08-01 Issue:2 Volume:92 Page:186-191
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Chilosi Marco¹,Semenzato Gianpietro¹,Vinante Fabrizio¹,Menestrina Fabio¹,Piazzola Elena¹,Focchiatti Valeria¹,Sabbioni Renata¹,Zanotti Roberta¹,Pizzolo Giovanni¹

Affiliation:

1. Istituto di Anatomia Patologica, Verona University; Istituto di Medicina Clinica, Padova University; Cattedra di Oncologia and Cattedra di Ematologia, Verona University, Italy

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/92/2/186/26439934/ajcpath92-0186.pdf

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble interleukin‐2 receptor (sIL‐2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis;European Journal of Haematology;2020-05-28

2. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma;Annals of Hematology;2017-09-05

3. New insights of common gamma chain in hematological malignancies;Cytokine;2017-01

4. The clinical characteristics of patients with IgG4-related disease with infiltration of the labial salivary gland by IgG4-positive cells;Modern Rheumatology;2014-03-26

5. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma;Clinica Chimica Acta;2014-03